Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Central role of paxillin phosphorylation in regulation of LFA-1 integrins activity and lymphocyte migration.

Romanova LY, Mushinski JF.

Cell Adh Migr. 2011 Nov-Dec;5(6):457-62. doi: 10.4161/cam.5.6.18219. Review.

2.

Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia.

LeGrand J, Park ES, Wang H, Gupta S, Owens JD Jr, Nelson PJ, DuBois W, Bair T, Janz S, Mushinski JF.

Blood. 2012 Jan 26;119(4):1018-28. doi: 10.1182/blood-2011-06-363887. Epub 2011 Dec 6.

3.

Phosphorylation of paxillin at threonine 538 by PKCdelta regulates LFA1-mediated adhesion of lymphoid cells.

Romanova LY, Holmes G, Bahte SK, Kovalchuk AL, Nelson PJ, Ward Y, Gueler F, Mushinski JF.

J Cell Sci. 2010 May 1;123(Pt 9):1567-77. doi: 10.1242/jcs.060996. Epub 2010 Apr 13.

4.

Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.

Mushinski JF, Nguyen P, Stevens LM, Khanna C, Lee S, Chung EJ, Lee MJ, Kim YS, Linehan WM, Horisberger MA, Trepel JB.

J Biol Chem. 2009 May 29;284(22):15206-14. doi: 10.1074/jbc.M806324200. Epub 2009 Mar 18.

5.

The identification of microRNAs in a genomically unstable region of human chromosome 8q24.

Huppi K, Volfovsky N, Runfola T, Jones TL, Mackiewicz M, Martin SE, Mushinski JF, Stephens R, Caplen NJ.

Mol Cancer Res. 2008 Feb;6(2):212-21. doi: 10.1158/1541-7786.MCR-07-0105.

6.

Gene expression profiling reveals different pathways related to Abl and other genes that cooperate with c-Myc in a model of plasma cell neoplasia.

Park ES, Shaughnessy JD Jr, Gupta S, Wang H, Lee JS, Woo HG, Zhan F, Owens JD Jr, Potter M, Janz S, Mushinski JF.

BMC Genomics. 2007 Aug 31;8:302.

7.
8.

Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.

Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M.

J Biol Chem. 2005 Jul 29;280(30):27728-41. Epub 2005 Apr 18. Erratum in: J Biol Chem. 2005 Sep 16;280(37):32564.

9.

Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.

Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC 3rd, Janz S.

Cancer Res. 2005 Feb 15;65(4):1306-15.

10.

Phosphorylation of paxillin tyrosines 31 and 118 controls polarization and motility of lymphoid cells and is PMA-sensitive.

Romanova LY, Hashimoto S, Chay KO, Blagosklonny MV, Sabe H, Mushinski JF.

J Cell Sci. 2004 Aug 1;117(Pt 17):3759-68. Epub 2004 Jul 13.

11.
12.

c-Myc-induced genomic instability.

Mai S, Mushinski JF.

J Environ Pathol Toxicol Oncol. 2003;22(3):179-99. Review.

PMID:
14529093
13.

Induction of apoptosis by protein kinase C delta is independent of its kinase activity.

Goerke A, Sakai N, Gutjahr E, Schlapkohl WA, Mushinski JF, Haller H, Kolch W, Saito N, Mischak H.

J Biol Chem. 2002 Aug 30;277(35):32054-62. Epub 2002 Jun 7.

14.

Linkage of caspase-mediated degradation of paxillin to apoptosis in Ba/F3 murine pro-B lymphocytes.

Chay KO, Park SS, Mushinski JF.

J Biol Chem. 2002 Apr 26;277(17):14521-9. Epub 2002 Feb 1.

15.

Multiple isoforms of protein kinase C in lymphocytes and airway smooth muscle of guinea pig.

Fatma S, Mushinski JF, Bansal SK.

Indian J Biochem Biophys. 2001 Aug;38(4):280-4.

PMID:
11811627
16.

A preservation method that allows recovery of intact RNA from tissues dissected by laser capture microdissection.

Parlato R, Rosica A, Cuccurullo V, Mansi L, Macchia P, Owens JD, Mushinski JF, De Felice M, Bonner RF, Di Lauro R.

Anal Biochem. 2002 Jan 15;300(2):139-45.

PMID:
11779104
18.

Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.

Kim JS, Pirnia F, Choi YH, Nguyen PM, Knepper B, Tsokos M, Schulte TW, Birrer MJ, Blagosklonny MV, Schaefer O, Mushinski JF, Trepel JB.

Oncogene. 2000 Dec 7;19(52):6082-90.

19.

1-Methylguanosine in place of Y base at position 37 in phenylalanine tRNA is responsible for its shiftiness in retroviral ribosomal frameshifting.

Carlson BA, Mushinski JF, Henderson DW, Kwon SY, Crain PF, Lee BJ, Hatfield DL.

Virology. 2001 Jan 5;279(1):130-5.

20.

Identification of the smooth muscle-specific protein, sm22, as a novel protein kinase C substrate using two-dimensional gel electrophoresis and mass spectrometry.

Dammeier S, Lovric J, Eulitz M, Kolch W, Mushinski JF, Mischak H.

Electrophoresis. 2000 Jul;21(12):2443-53.

PMID:
10939458
21.

Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression.

Mai S, Hanley-Hyde J, Rainey GJ, Kuschak TI, Paul JT, Littlewood TD, Mischak H, Stevens LM, Henderson DW, Mushinski JF.

Neoplasia. 1999 Aug;1(3):241-52.

22.

The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.

Kuschak TI, Taylor C, McMillan-Ward E, Israels S, Henderson DW, Mushinski JF, Wright JA, Mai S.

Gene. 1999 Oct 1;238(2):351-65.

PMID:
10570963
23.

Myc-induced cyclin D2 genomic instability in murine B cell neoplasms.

Mushinski JF, Hanley-Hyde J, Rainey GJ, Kuschak TI, Taylor C, Fluri M, Stevens LM, Henderson DW, Mai S.

Curr Top Microbiol Immunol. 1999;246:183-9; discussion 190-2. Review. No abstract available.

PMID:
10396055
24.

Regulation of actin cytoskeleton in lymphocytes: PKC-delta disrupts IL-3-induced membrane ruffles downstream of Rac1.

Romanova LY, Alexandrov IA, Blagosklonny MV, Nordan RP, Garfield S, Acs P, Nguyen P, Trepel J, Blumberg PM, Mushinski JF.

J Cell Physiol. 1999 May;179(2):157-69.

PMID:
10199555
25.

bcl2 and v-abl oncogenes cooperate to immortalize murine B cells that secrete antigen specific antibodies.

Kumar A, Ta D, Henderson D, Mushinski JF, Reed JC, Kuus-Reichel K, Saedi MS.

Immunol Lett. 1999 Feb;65(3):153-9.

PMID:
10065737
26.

Modulation of MAP kinase signaling and growth characteristics by the overexpression of protein kinase C in NIH3T3 cells.

Chang YY, Kim SJ, Park TK, Kang SS, Ha MJ, Mushinski JF, Chun JS.

Biochem Mol Biol Int. 1998 Sep;45(6):1139-48.

PMID:
9762412
27.

Generation of switch hybrid DNA between Ig heavy chain-mu and downstream switch regions in B lymphocytes.

Müller JR, Giese T, Henry DL, Mushinski JF, Marcu KB.

J Immunol. 1998 Aug 1;161(3):1354-62.

28.

Activation of bcl-2 suppressible 40 and 44 kDa p38-like kinases during apoptosis of early and late B lymphocytic cell lines.

Maucher C, Weissinger EM, Kremmer E, Baccarini M, Procyk K, Henderson DW, Wolff L, Kolch W, Kaspers B, Mushinski JF, Mischak H.

FEBS Lett. 1998 May 1;427(1):29-35.

29.
31.

Both the catalytic and regulatory domains of protein kinase C chimeras modulate the proliferative properties of NIH 3T3 cells.

Acs P, Wang QJ, Bögi K, Marquez AM, Lorenzo PS, Bíró T, Szállási Z, Mushinski JF, Blumberg PM.

J Biol Chem. 1997 Nov 7;272(45):28793-9.

32.

Decoupling of DNA excision repair and RNA transcription in translocation breaksite regions of plasmacytoma-susceptible BALB/cAnPt mice.

Beecham EJ, Owens JD, Shaughnessy JD Jr, Huppi K, Bohr VA, Mushinski JF.

Carcinogenesis. 1997 Apr;18(4):687-94.

PMID:
9111201
33.
34.

The ABL-MYC retrovirus generates antigen-specific plasmacytomas by in vitro infection of activated B lymphocytes from spleen and other murine lymphoid organs.

Largaespada DA, Jackson MW, Thompson NE, Kaehler DA, Byrd LG, Mushinski JF.

J Immunol Methods. 1996 Oct 16;197(1-2):85-95.

PMID:
8890896
35.

Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.

Schulte TW, Blagosklonny MV, Romanova L, Mushinski JF, Monia BP, Johnston JF, Nguyen P, Trepel J, Neckers LM.

Mol Cell Biol. 1996 Oct;16(10):5839-45.

36.

Mechanism of apoptosis suppression by phorbol ester in IL-6-starved murine plasmacytomas: role of PKC modulation and cell cycle.

Romanova LY, Alexandrov IA, Schwab G, Hilbert DM, Mushinski JF, Nordan RP.

Biochemistry. 1996 Jul 30;35(30):9900-6.

PMID:
8703964
38.

Protein kinase C-zeta reverts v-raf transformation of NIH-3T3 cells.

Kieser A, Seitz T, Adler HS, Coffer P, Kremmer E, Crespo P, Gutkind JS, Henderson DW, Mushinski JF, Kolch W, Mischak H.

Genes Dev. 1996 Jun 15;10(12):1455-66.

39.

Cloning and characterisation of genes (pkc1 and pkcA) encoding protein kinase C homologues from Trichoderma reesei and Aspergillus niger.

Morawetz R, Lendenfeld T, Mischak H, Mühlbauer M, Gruber F, Goodnight J, de Graaff LH, Visser J, Mushinski JF, Kubicek CP.

Mol Gen Genet. 1996 Jan 15;250(1):17-28.

PMID:
8569684
40.
42.

Association of elevated levels of protein kinase C-zeta mRNA and protein with murine B-lymphocytic neoplasia.

Goodnight J, Mischak H, Mushinski JF.

Mol Carcinog. 1994 Nov;11(3):131-7.

PMID:
7945801
43.

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins.

Roden RB, Weissinger EM, Henderson DW, Booy F, Kirnbauer R, Mushinski JF, Lowy DR, Schiller JT.

J Virol. 1994 Nov;68(11):7570-4.

44.

Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1).

Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S, Mock B, Givol D, Mushinski JF.

Oncogene. 1994 Oct;9(10):3017-20.

PMID:
8084607
45.

Expression of c-cbl proto-oncogene is modulated during differentiation but not during induction of proliferation.

Mushinski JF, Goodnight J, Rudikoff E, Morse HC 3rd, Langdon WY.

Oncogene. 1994 Sep;9(9):2489-97.

PMID:
8058312
47.
48.

DNA repair defects associated with chromosomal translocation breaksite regions.

Beecham EJ, Jones GM, Link C, Huppi K, Potter M, Mushinski JF, Bohr VA.

Mol Cell Biol. 1994 Feb;14(2):1204-12.

49.

Tyrosine phosphorylation of protein kinase C-delta in response to its activation.

Li W, Mischak H, Yu JC, Wang LM, Mushinski JF, Heidaran MA, Pierce JH.

J Biol Chem. 1994 Jan 28;269(4):2349-52.

50.

Induction of plasmacytomas that secrete monoclonal anti-peptide antibodies by retroviral transformation.

Weissinger EM, Henderson DW, Mischak H, Goodnight J, Mushinski JF.

J Immunol Methods. 1994 Jan 12;168(1):123-30.

PMID:
8288888

Supplemental Content

Loading ...
Support Center